Sponsors

Microscopy of cutaneous malignancies: an H&E subtype evaluation

Frozen section and H&E staining are an integral part of the support for patients undergoing Mohs micrographic surgery. Here, Jeyrroy Gabriel and colleagues report on a focused assessment of haematoxylin staining sensitivity and specificity.

Non-melanoma keratinocyte carcinomas are on the rise, with around 156,000 cases diagnosed annually in the United Kingdom.1 Basal cell carcinoma (BCC) is the most predominant form encountered.2 In recent years, Mohs micrographic surgery has gained popularity for the treatment of BCC due to the rapid result turnaround, improved surgical results and preservation of healthy tissue.3

            The Mohs technique employs mainly haematoxylin and eosin (H&E)-stained frozen sections for surgical margin assessment of cutaneous excisions, utilising microscopic evaluation of the complete, circumferential, peripheral and deep margins.

            This study aimed to determine which mordant-based haematoxylin (Ehrlich, Cole, Mayer, Gill I, Gill II, Gill III, Weigert, Harris or Carazzi) produced the optimal morphological clarity of staining for the identification of cellular morphology of cutaneous BCC.

Log in or register FREE to read the rest

This story is Premium Content and is only available to registered users. Please log in at the top of the page to view the full text. If you don't already have an account, please register with us completely free of charge.

Latest Issues

The Power to Disrupt - Clinical Diagnostics Expo UK

15 Hatfields
16 September, 2024

Microbe Conference 2024

Crowne Plaza Hotel, Sheffield, UK
20-22 September, 2024

Cardiac Marker Dialogues: Cardiac Biomarkers in Real Time – Experiences and Opportunities

Hilton Glasgow, 1 William Street, Glasgow, Scotland, G3 8HT
26-27 September, 2024

The British Association for Cytopathology Annual Scientific Meeting

Aztec Hotel and Spa, Bristol, BS32 4TS
18 October, 2024

UK NEQAS: Navigating Quality Standards in Point of Care Testing

The Hyatt Regency Hotel, Birmingham, UK
23 October, 2024